| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | TBC1D2 EIF3E ITGA2 ITGA7 PPP1R13L FAP PTPRM DLG1 CNGA3 MPP7 FERMT3 FLNB ITGA11 TNC GLOD4 EEF1G TENM3 MACF1 EPCAM | 6.20e-05 | 599 | 228 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MCM8 KIF1A KIF1B RSF1 DHX8 ATP11B DNAH6 KIF13B DDX17 ATP13A1 CHD1L DICER1 ERCC6L2 HLTF UBA6 MACF1 ATP2B1 KIF1C | 2.56e-04 | 614 | 228 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | GTPBP4 MCM8 KIF1A KIF1B RSF1 DHX8 ATP11B ENPP5 GNAL GNAQ DNAH6 PRUNE2 KIF13B DDX17 ATP13A1 CHD1L RHEB HLTF MACF1 RGS17 ATP2B1 KIF1C | 2.63e-04 | 840 | 228 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GTPBP4 MCM8 KIF1A KIF1B RSF1 DHX8 ATP11B ENPP5 GNAL GNAQ DNAH6 PRUNE2 KIF13B DDX17 ATP13A1 CHD1L RHEB HLTF MACF1 RGS17 ATP2B1 KIF1C | 2.63e-04 | 840 | 228 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | serine-type exopeptidase activity | 3.00e-04 | 12 | 228 | 3 | GO:0070008 | |
| GeneOntologyMolecularFunction | tripeptidyl-peptidase activity | 3.86e-04 | 3 | 228 | 2 | GO:0008240 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.22e-04 | 33 | 228 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | cadherin binding | TBC1D2 EIF3E PPP1R13L PTPRM DLG1 CNGA3 MPP7 FLNB GLOD4 EEF1G MACF1 EPCAM | 5.51e-04 | 339 | 228 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MCM8 KIF1A KIF1B RSF1 DHX8 ATP11B DNAH6 KIF13B DDX17 ATP13A1 CHD1L MACF1 ATP2B1 KIF1C | 5.76e-04 | 441 | 228 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | GTPBP4 MCM8 KIF1A KIF1B RSF1 DHX8 ATP11B ENPP5 GNAL GNAQ DNAH6 PRUNE2 KIF13B DDX17 ATP13A1 CHD1L RHEB MACF1 RGS17 ATP2B1 KIF1C | 6.55e-04 | 839 | 228 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.67e-04 | 4 | 228 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.14e-04 | 37 | 228 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 8.88e-04 | 17 | 228 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.06e-03 | 18 | 228 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 1.06e-03 | 18 | 228 | 3 | GO:0016722 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.23e-03 | 70 | 228 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 1.27e-03 | 5 | 228 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 1.27e-03 | 5 | 228 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | poly-ADP-D-ribose modification-dependent protein binding | 1.27e-03 | 5 | 228 | 2 | GO:0160004 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 9.83e-07 | 8 | 228 | 4 | GO:1990048 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 6.71e-06 | 12 | 228 | 4 | GO:0099519 | |
| GeneOntologyBiologicalProcess | neuron development | MAG KIF1A MAP1B MAP2 FRMD7 LAMA1 DGKG TSC1 PLXNB2 CHRNB2 ITPR1 STMN4 PTPRM PTPRS MANF PCDH15 SYN1 ALCAM GNAQ CNGA3 KIF13B SLC11A2 NEDD4L TNC CASP3 ARFGEF1 THOC2 DICER1 CELSR2 TENM3 MTOR UBA6 MTR MACF1 MUSK | 1.25e-05 | 1463 | 228 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | dense core granule transport | 1.33e-05 | 14 | 228 | 4 | GO:1901950 | |
| GeneOntologyBiologicalProcess | neuron projection development | MAG KIF1A MAP1B MAP2 FRMD7 LAMA1 DGKG TSC1 PLXNB2 CHRNB2 ITPR1 STMN4 PTPRM PTPRS MANF PCDH15 ALCAM KIF13B SLC11A2 NEDD4L TNC CASP3 ARFGEF1 THOC2 DICER1 CELSR2 TENM3 MTOR UBA6 MTR MACF1 MUSK | 1.40e-05 | 1285 | 228 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 2.60e-05 | 6 | 228 | 3 | GO:1990049 | |
| GeneOntologyBiologicalProcess | response to wounding | MAG MAP1B DGKG ITGA2 F5 FAP PTPRS C5 GNAQ FERMT3 TNC CASP3 ARFGEF1 CASP7 MTOR SERPINB2 MTR MACF1 UBASH3B DCBLD2 | 4.67e-05 | 659 | 228 | 20 | GO:0009611 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG PLXNB2 CD84 FAT1 FAT2 PTPRM PTPRS PCDH15 ALCAM PCDHB15 CELSR2 TENM3 EPCAM | 4.88e-05 | 313 | 228 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.26e-05 | 62 | 228 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | MAP1B TSC1 TLR7 RFTN2 ITGA2 ACE CHRNB2 RYR2 RYR3 ITPR1 TYR GGH FAT1 PRMT5 GNAL GNAQ CNGA3 HOMER2 CACNA2D1 FPR2 CASP3 CASP7 CPS1 NPLOC4 MTOR MTR RGS17 ATP2B1 SORL1 SOS2 | 7.23e-05 | 1272 | 228 | 30 | GO:1901698 |
| GeneOntologyBiologicalProcess | response to alkaloid | 7.65e-05 | 125 | 228 | 8 | GO:0043279 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | MAP1B KDM4C TLR7 RFTN2 ITGA2 SSTR1 ACE CHRNB2 RYR2 RYR3 ITPR1 TYR PRMT5 SCN5A GNAL GNAQ CNGA3 HOMER2 SMYD3 DDX17 TNC CASP3 CASP7 CPS1 TIPARP MTOR | 1.02e-04 | 1048 | 228 | 26 | GO:0014070 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MAG KIF1A MAP1B MAP2 LAMA1 ITGA7 PLXNB2 CHRNB2 ITPR1 FAT1 PTPRM PTPRS PCDH15 DLG1 FGD5 ALCAM KIT KIF13B FLNB SLC11A2 RILPL2 NEDD4L CASP3 CFAP43 THOC2 DICER1 CELSR2 MACF1 | 1.41e-04 | 1194 | 228 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | MAG KIF1A MAP1B MAP2 FRMD7 DGKG TSC1 PLXNB2 CHRNB2 ITPR1 PTPRS KIF13B NEDD4L THOC2 TENM3 MTOR MACF1 MUSK | 1.66e-04 | 612 | 228 | 18 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MAG MAP1B MAP2 LRRTM3 ACE PLXNB2 PTPRS PRMT5 DLG1 KIT TF DICER1 RHEB MTOR HLTF MACF1 MUSK SORL1 | 2.15e-04 | 625 | 228 | 18 | GO:0051960 |
| GeneOntologyBiologicalProcess | dense core granule localization | 2.42e-04 | 28 | 228 | 4 | GO:0032253 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.44e-04 | 187 | 228 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAG KIF1A MAP1B MAP2 FRMD7 TBC1D2 DGKG TSC1 ITGA2 PLXNB2 CHRNB2 ITPR1 PTPRS KIT KIF13B NEDD4L MIEN1 THOC2 TENM3 MTOR MACF1 MUSK | 2.45e-04 | 863 | 228 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 2.72e-04 | 12 | 228 | 3 | GO:0071421 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | MAP1B ACE CHRNB2 RYR2 RYR3 ITPR1 FAT1 PRMT5 GNAL GNAQ CACNA2D1 FPR2 CASP3 CASP7 CPS1 MTOR MTR ATP2B1 SORL1 SOS2 | 2.74e-04 | 752 | 228 | 20 | GO:1901699 |
| GeneOntologyCellularComponent | asymmetric synapse | MAP1B MAP2 EIF3E TSC1 LRRTM3 ITPR1 PTPRS SYN1 DLG1 HOMER2 DRP2 CASP3 ARFGEF2 DICER1 SHISA7 RHEB MACF1 | 2.20e-05 | 477 | 229 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF1A MAP1B MAP2 FRMD7 KIF1B KLHL20 ITPR1 PTPRS SYN1 DLG1 ALCAM GNAQ USH2A CNGA3 HOMER2 FLNB DRP2 COPA GLRX3 CASP3 ARFGEF2 TF DICER1 SHISA7 RHEB MTOR BRINP2 ATP2B1 KIF1C SORL1 | 3.24e-05 | 1228 | 229 | 30 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic density | MAP1B MAP2 EIF3E TSC1 LRRTM3 ITPR1 PTPRS SYN1 DLG1 HOMER2 DRP2 CASP3 DICER1 SHISA7 RHEB MACF1 | 4.06e-05 | 451 | 229 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP1B MAP2 EIF3E TSC1 LRRTM3 CHRNB2 ITPR1 PTPRS SYN1 DLG1 HOMER2 DRP2 CASP3 DICER1 SHISA7 RHEB MACF1 | 4.28e-05 | 503 | 229 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | axon | MAG KIF1A MAP1B MAP2 FRMD7 KIF1B TSC1 ITGA2 KLHL20 STMN4 SYNJ2 PTPRS SCN4A SCN5A SYN1 DLG1 ALCAM USH2A CNGA3 KIF13B COPA DICER1 TENM3 KIF1C | 4.74e-05 | 891 | 229 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP1B MAP2 EIF3E TSC1 LRRTM3 ITPR1 PTPRS SYN1 DLG1 HOMER2 DRP2 CASP3 ARFGEF2 DICER1 SHISA7 RHEB MACF1 | 6.91e-05 | 523 | 229 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | dendrite | KIF1A MAP1B MAP2 KIF1B KLHL20 ITPR1 SYN1 DLG1 ALCAM GNAQ CNGA3 HOMER2 DRP2 GLRX3 ARFGEF2 TF DICER1 SHISA7 RHEB MTOR BRINP2 ATP2B1 KIF1C | 7.38e-05 | 858 | 229 | 23 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | KIF1A MAP1B MAP2 KIF1B KLHL20 ITPR1 SYN1 DLG1 ALCAM GNAQ CNGA3 HOMER2 DRP2 GLRX3 ARFGEF2 TF DICER1 SHISA7 RHEB MTOR BRINP2 ATP2B1 KIF1C | 7.64e-05 | 860 | 229 | 23 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | KIF1A MAP1B MAP2 KIF1B EIF3E TSC1 LRRTM3 CHRNB2 ITPR1 PTPRS SYN1 DLG1 HOMER2 DOCK1 CACNA2D1 DRP2 CASP3 ARFGEF2 DICER1 SHISA7 RHEB MTOR MACF1 ATP2B1 MUSK | 1.42e-04 | 1018 | 229 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.11e-04 | 185 | 229 | 9 | GO:0009898 | |
| GeneOntologyCellularComponent | side of membrane | ITGA2 ITGA7 ACE CHRNB2 RYR2 RYR3 PGM5 CD84 MS4A2 MUC17 DLG1 ALCAM GNAL GNAQ KIT ITGA11 TRGC2 MIEN1 LEPR ATP2B1 ENPEP MUSK | 2.62e-04 | 875 | 229 | 22 | GO:0098552 |
| GeneOntologyCellularComponent | cell projection membrane | MAP2 ACE FAP MUC17 SYNJ2 DLG1 FGD5 USH2A WWC1 SLC11A2 SHISA7 MACF1 ATP2B1 ENPEP | 3.05e-04 | 431 | 229 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | microtubule associated complex | 4.10e-04 | 161 | 229 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ITGA2 ITGA7 CHRNB2 PGM5 MS4A2 SCN4A SCN5A DLG1 ALCAM GNAL C5 GNAQ MPP7 CACNA2D1 ITGA11 TRGC2 CASP3 TF SHISA7 TRBV4-1 | 4.24e-04 | 785 | 229 | 20 | GO:0098797 |
| GeneOntologyCellularComponent | main axon | 4.41e-04 | 89 | 229 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 4.67e-04 | 59 | 229 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.33e-04 | 210 | 229 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | cell body | KIF1A MAP1B MAP2 FRMD7 ITPR1 PTPRS SYN1 DLG1 ALCAM GNAQ USH2A CNGA3 HOMER2 FLNB DRP2 COPA CASP3 RHEB MTOR BRINP2 ATP2B1 SORL1 | 5.90e-04 | 929 | 229 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GTPBP4 KIF1A MAP1B TSC1 ITGA2 KLHL20 RYR3 ITPR1 TYR FAT1 PTPRM SYNJ2 SCN5A MANF DLG1 WWC1 SLC11A2 ARFGEF2 ARFGEF1 TF DICER1 SORL1 | 6.33e-04 | 934 | 229 | 22 | GO:0048471 |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP1B MAP2 LRRTM3 PPM1H PTPRS DLG1 HOMER2 DOCK1 PRUNE2 CACNA2D1 DRP2 NEDD4L CASP3 ARFGEF2 DICER1 SHISA7 RHEB TENM3 MTOR ATP2B1 | 6.99e-04 | 817 | 229 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | paranode region of axon | 7.88e-04 | 17 | 229 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 8.19e-04 | 223 | 229 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | neuronal cell body | KIF1A MAP1B MAP2 FRMD7 ITPR1 PTPRS DLG1 ALCAM USH2A CNGA3 HOMER2 FLNB DRP2 COPA CASP3 RHEB MTOR BRINP2 ATP2B1 SORL1 | 9.13e-04 | 835 | 229 | 20 | GO:0043025 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.02e-03 | 230 | 229 | 9 | GO:0098562 | |
| GeneOntologyCellularComponent | MPP7-DLG1-LIN7 complex | 1.17e-03 | 5 | 229 | 2 | GO:0097025 | |
| GeneOntologyCellularComponent | cell surface | ITGA2 ITGA7 ACE PLXNB2 VWDE CHRNB2 CD84 FAP MS4A2 MUC17 SCN5A ALCAM KIT ITGA11 SLC11A2 TRGC2 TF LEPR CUZD1 EPCAM ENPEP DCBLD2 MUSK SORL1 | 1.20e-03 | 1111 | 229 | 24 | GO:0009986 |
| GeneOntologyCellularComponent | ruffle membrane | 1.22e-03 | 108 | 229 | 6 | GO:0032587 | |
| GeneOntologyCellularComponent | external side of plasma membrane | ITGA2 ITGA7 ACE CHRNB2 CD84 MS4A2 MUC17 ALCAM KIT ITGA11 TRGC2 LEPR ENPEP MUSK | 1.83e-03 | 519 | 229 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | receptor complex | TLR7 ITGA2 ITGA7 PLXNB2 CHRNB2 ALCAM KIT IMPG2 ITGA11 TRGC2 TF SHISA7 LEPR TRBV4-1 MUSK | 1.95e-03 | 581 | 229 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | kinesin complex | 2.02e-03 | 49 | 229 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | basement membrane | 2.28e-03 | 122 | 229 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | anchoring junction | LAMA1 TBC1D2 ITGA2 ITGA7 PGM5 FAP FCHSD2 FAT1 FAT2 PTPRM SCN5A DLG1 ALCAM KIT MPP7 FERMT3 FLNB ITGA11 TNC SLC4A2 EPCAM | 2.54e-03 | 976 | 229 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | KIF1A MAP2 KIF1B TOGARAM1 CFAP77 DNAH6 ARFGEF2 CFAP43 DNAI3 KIF1C | 2.71e-03 | 317 | 229 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.83e-03 | 88 | 229 | 5 | GO:0016529 | |
| Domain | Kinesin_assoc | 3.24e-07 | 6 | 229 | 4 | PF16183 | |
| Domain | Kinesin_assoc | 3.24e-07 | 6 | 229 | 4 | IPR032405 | |
| Domain | Kinesin-like_KIF1-typ | 7.21e-06 | 4 | 229 | 3 | IPR022140 | |
| Domain | KIF1B | 7.21e-06 | 4 | 229 | 3 | PF12423 | |
| Domain | Ryanodine_recept-rel | 3.54e-05 | 6 | 229 | 3 | IPR015925 | |
| Domain | - | 3.54e-05 | 6 | 229 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 3.54e-05 | 6 | 229 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.54e-05 | 6 | 229 | 3 | PF08709 | |
| Domain | Kinesin-like | 3.54e-05 | 6 | 229 | 3 | IPR022164 | |
| Domain | RIH_assoc | 3.54e-05 | 6 | 229 | 3 | PF08454 | |
| Domain | RIH_dom | 3.54e-05 | 6 | 229 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.54e-05 | 6 | 229 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 3.54e-05 | 6 | 229 | 3 | PF01365 | |
| Domain | DUF3694 | 3.54e-05 | 6 | 229 | 3 | PF12473 | |
| Domain | SMAD_FHA_domain | 4.04e-05 | 52 | 229 | 6 | IPR008984 | |
| Domain | Laminin_G | 7.56e-05 | 58 | 229 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 9.57e-05 | 38 | 229 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 1.23e-04 | 40 | 229 | 5 | PF02210 | |
| Domain | LamG | 1.95e-04 | 44 | 229 | 5 | SM00282 | |
| Domain | MIR | 2.05e-04 | 10 | 229 | 3 | PF02815 | |
| Domain | MIR_motif | 2.05e-04 | 10 | 229 | 3 | IPR016093 | |
| Domain | MIR | 2.05e-04 | 10 | 229 | 3 | PS50919 | |
| Domain | MIR | 2.05e-04 | 10 | 229 | 3 | SM00472 | |
| Domain | EGF-like_dom | MASP1 LAMA1 VWDE FAT1 FAT2 MUC17 IMPG2 TNC CELSR2 TENM3 SORL1 | 2.64e-04 | 249 | 229 | 11 | IPR000742 |
| Domain | EGF_1 | MASP1 LAMA1 VWDE FAT1 FAT2 MUC17 USH2A IMPG2 TNC CELSR2 TENM3 | 3.23e-04 | 255 | 229 | 11 | PS00022 |
| Domain | FHA | 3.58e-04 | 28 | 229 | 4 | SM00240 | |
| Domain | ConA-like_dom | 3.85e-04 | 219 | 229 | 10 | IPR013320 | |
| Domain | EGF-like_CS | MASP1 LAMA1 VWDE FAT1 FAT2 MUC17 IMPG2 TNC CELSR2 TENM3 SORL1 | 3.94e-04 | 261 | 229 | 11 | IPR013032 |
| Domain | RyR | 4.45e-04 | 3 | 229 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 4.45e-04 | 3 | 229 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.45e-04 | 3 | 229 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 4.45e-04 | 3 | 229 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.45e-04 | 3 | 229 | 2 | IPR009460 | |
| Domain | EGF_2 | MASP1 LAMA1 VWDE FAT1 FAT2 MUC17 IMPG2 TNC CELSR2 TENM3 SORL1 | 4.47e-04 | 265 | 229 | 11 | PS01186 |
| Domain | FHA_DOMAIN | 5.34e-04 | 31 | 229 | 4 | PS50006 | |
| Domain | FHA | 5.34e-04 | 31 | 229 | 4 | PF00498 | |
| Domain | EGF | 6.68e-04 | 235 | 229 | 10 | SM00181 | |
| Domain | EGF_3 | 6.68e-04 | 235 | 229 | 10 | PS50026 | |
| Domain | DCB_dom | 8.84e-04 | 4 | 229 | 2 | IPR032629 | |
| Domain | Sec7_N | 8.84e-04 | 4 | 229 | 2 | PF12783 | |
| Domain | DCB | 8.84e-04 | 4 | 229 | 2 | PF16213 | |
| Domain | RetinoicA-induced_16-like | 8.84e-04 | 4 | 229 | 2 | IPR019384 | |
| Domain | RAI16-like | 8.84e-04 | 4 | 229 | 2 | PF10257 | |
| Domain | Sec7_C | 8.84e-04 | 4 | 229 | 2 | IPR015403 | |
| Domain | DUF1981 | 8.84e-04 | 4 | 229 | 2 | PF09324 | |
| Domain | Sec7_N | 8.84e-04 | 4 | 229 | 2 | IPR032691 | |
| Domain | Pept_S9_AS | 8.84e-04 | 4 | 229 | 2 | IPR002471 | |
| Domain | - | 9.53e-04 | 36 | 229 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 9.53e-04 | 36 | 229 | 4 | IPR000253 | |
| Domain | - | 1.12e-03 | 95 | 229 | 6 | 2.60.120.200 | |
| Domain | INTEGRIN_ALPHA | 1.30e-03 | 18 | 229 | 3 | PS00242 | |
| Domain | Integrin_alpha | 1.30e-03 | 18 | 229 | 3 | IPR000413 | |
| Domain | Integrin_alpha-2 | 1.30e-03 | 18 | 229 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.30e-03 | 18 | 229 | 3 | PF08441 | |
| Domain | PRO_ENDOPEP_SER | 1.46e-03 | 5 | 229 | 2 | PS00708 | |
| Domain | Cu-oxidase_3 | 1.46e-03 | 5 | 229 | 2 | IPR011707 | |
| Domain | Cu-oxidase_3 | 1.46e-03 | 5 | 229 | 2 | PF07732 | |
| Domain | MULTICOPPER_OXIDASE1 | 1.46e-03 | 5 | 229 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 1.46e-03 | 5 | 229 | 2 | IPR033138 | |
| Domain | Int_alpha | 1.52e-03 | 19 | 229 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.52e-03 | 19 | 229 | 3 | IPR013519 | |
| Domain | Kinesin_motor_CS | 1.56e-03 | 41 | 229 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.87e-03 | 43 | 229 | 4 | IPR027640 | |
| Domain | Kinesin | 2.03e-03 | 44 | 229 | 4 | PF00225 | |
| Domain | KISc | 2.03e-03 | 44 | 229 | 4 | SM00129 | |
| Domain | Kinesin_motor_dom | 2.03e-03 | 44 | 229 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.03e-03 | 44 | 229 | 4 | PS50067 | |
| Domain | - | 2.03e-03 | 44 | 229 | 4 | 3.40.850.10 | |
| Domain | KINESIN_MOTOR_1 | 2.03e-03 | 44 | 229 | 4 | PS00411 | |
| Domain | Helicase_C | 2.05e-03 | 107 | 229 | 6 | PF00271 | |
| Domain | HELICc | 2.05e-03 | 107 | 229 | 6 | SM00490 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.11e-05 | 13 | 162 | 4 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.69e-05 | 19 | 162 | 4 | M47760 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 9.15e-05 | 159 | 162 | 9 | M39373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.05e-04 | 22 | 162 | 4 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.25e-04 | 23 | 162 | 4 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY | 2.30e-04 | 11 | 162 | 3 | M47915 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.36e-04 | 76 | 162 | 6 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 2.77e-04 | 28 | 162 | 4 | M47655 | |
| Pathway | WP_IRON_METABOLISM_IN_PLACENTA | 3.04e-04 | 12 | 162 | 3 | M39660 | |
| Pathway | REACTOME_HEMOSTASIS | MAG KIF1A KIF1B DGKG F5 ITPR1 CD84 MANF GNAQ FERMT3 DOCK1 KIF13B TF SERPINB2 EPCAM ATP2B1 KIF1C | 3.09e-04 | 571 | 162 | 17 | MM14472 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ATG4A TSC1 ACE SCN4A SCN5A DLG1 GNAQ KIT HOMER2 MMACHC RHEB MTOR MTR | 3.21e-04 | 367 | 162 | 13 | M48346 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 3.65e-04 | 30 | 162 | 4 | M47718 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.82e-04 | 83 | 162 | 6 | M8728 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 3.91e-04 | 13 | 162 | 3 | M47603 | |
| Pubmed | ACE F5 FAP FAT2 PTPRM PTPRS ALCAM C5 KIT SERPINA7 CACNA2D1 ATP13A1 TNC TF LEPR ENPEP | 2.70e-11 | 257 | 234 | 16 | 16335952 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAP1B LAMA1 ITGA2 ITGA7 PLXNB2 ITPR1 GGH FAP FAT1 MIA2 PTPRS PRMT5 MANF ALCAM CPVL CACNA2D1 ITGA11 NEDD4L COPA GLRX3 ARFGEF2 ARFGEF1 SLC4A2 CELSR2 TENM3 TTC17 TMEM131 ATP2B1 DCBLD2 SORL1 | 7.40e-10 | 1201 | 234 | 30 | 35696571 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAG FRMD7 TSC1 ITGA2 FAT1 PTPRM DLG1 ALCAM GNAQ MPP7 KIF13B SLC11A2 ARFGEF2 ARFGEF1 FCHO2 SLC4A2 CELSR2 MTOR ATP2B1 DCBLD2 | 2.29e-09 | 569 | 234 | 20 | 30639242 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MCM8 KIF1A MAP1B MAP2 KIF1B PPM1H ATP11B SYNJ2 PTPRS DLG1 ENPP5 ANKRD12 ALCAM ARHGAP8 SMYD3 DOCK1 TRMT9B PRUNE2 FLNB NEDD4L CHD1L BABAM2 NPLOC4 ZNF532 CDK13 UBA6 MACF1 TTC17 ATP2B1 DOP1A SOS2 | 2.66e-08 | 1489 | 234 | 31 | 28611215 |
| Pubmed | TPP2 GTPBP4 KIF1A MAP1B RSF1 EIF3E XAB2 DHX8 URB1 UBTF PRMT5 FLNB COPA THOC2 DICER1 IGF2BP2 MTOR PREP MACF1 | 1.15e-07 | 653 | 234 | 19 | 22586326 | |
| Pubmed | 3.01e-07 | 3 | 234 | 3 | 23404705 | ||
| Pubmed | 4.06e-07 | 10 | 234 | 4 | 32675284 | ||
| Pubmed | MAG TPP2 MAP1B MAP2 KIF1B TSC1 ITGA2 SARS1 PTPRS PRMT5 SYN1 DLG1 USP4 GNAQ DNAH6 FLNB CACNA2D1 DDX17 NEDD4L COPA TNC ARFGEF2 TF EEF1G AGO1 TRAPPC10 MACF1 ATP2B1 | 4.65e-07 | 1431 | 234 | 28 | 37142655 | |
| Pubmed | TPP2 GTPBP4 MAP1B EIF3E ITPR1 GGH URB1 UBTF PRMT5 NFKB2 CPVL COG4 FLNB CACNA2D1 COPA GLRX3 CASP7 FCHO2 THOC2 FHIP2A DICER1 NPLOC4 EEF1G IGF2BP2 MTOR HLTF TRAPPC10 ATP2B1 | 5.27e-07 | 1440 | 234 | 28 | 30833792 | |
| Pubmed | EIF3E PPP1R13L XAB2 RYR2 PLCL2 HTATSF1 FLNB NEDD4L GLRX3 ARFGEF2 EEF1G TENM3 CDK13 TRIM62 UBA6 MACF1 SMAD6 | 6.39e-07 | 591 | 234 | 17 | 15231748 | |
| Pubmed | EIF3E TSC1 PPP1R13L GTF3C4 DHX8 CEP350 TDRD3 SYNJ2 MANF DLG1 COG4 ATP13A1 CASP3 DICER1 SLC4A2 FAM193A MTR TTC17 TMEM131 | 6.63e-07 | 733 | 234 | 19 | 34672954 | |
| Pubmed | TPP2 GTPBP4 TSC1 TMEM132B PPM1H TDRD3 PTPRS SYN1 DLG1 HOMER2 FERMT3 KIF13B CACNA2D1 NEDD4L SHISA7 RHEB AGO1 CELSR2 MTOR UBA6 MACF1 UBASH3B | 7.09e-07 | 963 | 234 | 22 | 28671696 | |
| Pubmed | Gamma protocadherins are required for survival of spinal interneurons. | 7.74e-07 | 26 | 234 | 5 | 12467588 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | TSC1 ITGA2 ITGA7 SSTR1 GGH TNC CASP3 CASP7 CHD1L LEPR MTOR MTR RGS17 | 8.81e-07 | 351 | 234 | 13 | 20453000 |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.20e-06 | 4 | 234 | 3 | 23413940 | |
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 9607712 | ||
| Pubmed | Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease. | 1.20e-06 | 4 | 234 | 3 | 25351248 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GTPBP4 TOGARAM1 IP6K1 SLFN5 PPP1R13L F5 FAT1 HTATSF1 DNAH6 FHIP2B CHD1L CDK13 MACF1 | 1.20e-06 | 361 | 234 | 13 | 26167880 |
| Pubmed | PPP1R13L CEP350 TDRD3 SCML1 NFKB2 DDHD2 WWC1 DICER1 FAM193A MACF1 | 1.72e-06 | 209 | 234 | 10 | 36779422 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 MAP1B PLXNB2 F5 XAB2 DHX8 CEP350 URB1 UBTF PRMT5 FLNB CACNA2D1 DDX17 NEDD4L COPA THOC2 DICER1 EEF1G IGF2BP2 UBA6 MACF1 ATP2B1 | 1.94e-06 | 1024 | 234 | 22 | 24711643 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 MAP2 KIF1B TBC1D2 EIF3E GTF3C4 GGH SARS1 PRMT5 ARIH2 HTATSF1 PRUNE2 FLNB DDX17 COPZ1 COPA GLRX3 THUMPD3 ARFGEF2 CASP7 BABAM2 NPLOC4 EEF1G MTOR UBA6 MTR MACF1 | 2.06e-06 | 1455 | 234 | 27 | 22863883 |
| Pubmed | TPP2 MAP2 KLHL20 STMN4 SYN1 ANKRD12 DDHD2 COG4 COPA EEF1G TENM3 MACF1 | 2.19e-06 | 322 | 234 | 12 | 26514267 | |
| Pubmed | KIF1A KDM4C KIF1B GTF3C4 XAB2 RYR3 CEP350 MIA2 ARIH2 CCDC15 DLG1 ENPP5 COG4 SMYD3 FLNB COPA ATP13A1 ARFGEF2 TF ZNF181 ZNF532 MACF1 TTC17 TMEM131 SOS2 | 2.22e-06 | 1285 | 234 | 25 | 35914814 | |
| Pubmed | TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. | 2.98e-06 | 5 | 234 | 3 | 12172553 | |
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 38411613 | ||
| Pubmed | 3.41e-06 | 16 | 234 | 4 | 20880607 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MAG KIF1A EIF3E GTF3C4 RYR2 TDRD3 SARS1 DOCK1 DDX17 DICER1 IGF2BP2 AGO1 FAM193A TMEM131 | 3.51e-06 | 462 | 234 | 14 | 31138677 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPP2 GTPBP4 EIF3E TSC1 XAB2 DHX8 ZGPAT SARS1 MIA2 PRMT5 HTATSF1 FLNB DDX17 NEDD4L COPA GLRX3 GLOD4 CPS1 GRSF1 NPLOC4 EEF1G CDK13 HLTF UBA6 MACF1 KIF1C | 3.86e-06 | 1415 | 234 | 26 | 28515276 |
| Pubmed | 4.44e-06 | 17 | 234 | 4 | 34184027 | ||
| Pubmed | 4.44e-06 | 17 | 234 | 4 | 20413850 | ||
| Pubmed | 4.71e-06 | 234 | 234 | 10 | 36243803 | ||
| Pubmed | PLBD1 MASP1 MCM8 ARRDC1 GCNT4 FAP FCHSD2 MIA2 ATP11B DLG1 C5 DDHD2 EPYC FHIP2A GRSF1 CCDC7 TMEM184C | 4.74e-06 | 686 | 234 | 17 | 29987050 | |
| Pubmed | Architectural niche organization by LHX2 is linked to hair follicle stem cell function. | 5.68e-06 | 18 | 234 | 4 | 24012369 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.92e-06 | 6 | 234 | 3 | 25966694 | |
| Pubmed | Ubiquitination of Rheb governs growth factor-induced mTORC1 activation. | 5.92e-06 | 6 | 234 | 3 | 30514904 | |
| Pubmed | 5.92e-06 | 6 | 234 | 3 | 20519450 | ||
| Pubmed | Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. | 5.92e-06 | 6 | 234 | 3 | 12820960 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.92e-06 | 6 | 234 | 3 | 26025922 | |
| Pubmed | 5.92e-06 | 6 | 234 | 3 | 23463619 | ||
| Pubmed | 5.92e-06 | 6 | 234 | 3 | 11568114 | ||
| Pubmed | 5.92e-06 | 6 | 234 | 3 | 24184716 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.92e-06 | 6 | 234 | 3 | 16844763 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | DCAF1 MAP1B ARRDC1 LAMA1 PLXNB2 ATP11B PTPRS CACNA2D1 NEDD4L COPA MTR | 1.01e-05 | 313 | 234 | 11 | 38270169 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.01e-05 | 202 | 234 | 9 | 33005030 | |
| Pubmed | α2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2. | 1.03e-05 | 7 | 234 | 3 | 22138645 | |
| Pubmed | 1.03e-05 | 7 | 234 | 3 | 21321084 | ||
| Pubmed | 1.03e-05 | 7 | 234 | 3 | 11860456 | ||
| Pubmed | 1.03e-05 | 7 | 234 | 3 | 25368159 | ||
| Pubmed | 1.03e-05 | 7 | 234 | 3 | 21896734 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 KIF1A EIF3E DHX8 URB1 SARS1 UBTF PRMT5 FGD5 MGAM2 FLNB DDX17 COPA ATP13A1 THUMPD3 CASP7 GLOD4 THOC2 DICER1 GRSF1 EEF1G MTOR UBA6 MTR ATP2B1 | 1.31e-05 | 1425 | 234 | 25 | 30948266 |
| Pubmed | Assessment of Alzheimer's disease case-control associations using family-based methods. | 1.33e-05 | 22 | 234 | 4 | 18830724 | |
| Pubmed | 1.33e-05 | 22 | 234 | 4 | 35245678 | ||
| Pubmed | 1.60e-05 | 23 | 234 | 4 | 16637659 | ||
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.64e-05 | 8 | 234 | 3 | 25818806 | |
| Pubmed | GTPBP4 RSF1 GTF3C4 XAB2 UBTF PRMT5 ARIH2 HTATSF1 COPA GLRX3 CHD1L THOC2 BABAM2 NPLOC4 METTL14 EEF1G ZNF532 CDK13 HLTF UBA6 | 1.98e-05 | 1014 | 234 | 20 | 32416067 | |
| Pubmed | EIF3E PLXNB2 VWDE GGH PTPRS PRMT5 CPVL DDX17 COPA CPS1 LEPR EEF1G TTC17 TMEM131 SORL1 | 2.01e-05 | 613 | 234 | 15 | 22268729 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 MAP1B RSF1 TSC1 GTF3C4 XAB2 TDRD3 UBTF HTATSF1 DDX17 CASP3 GLOD4 THOC2 NPLOC4 RHEB EEF1G IGF2BP2 FAM193A MACF1 | 2.12e-05 | 934 | 234 | 19 | 33916271 |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.23e-05 | 171 | 234 | 8 | 20201926 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 2.26e-05 | 25 | 234 | 4 | 19373938 | |
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 2.26e-05 | 25 | 234 | 4 | 9275178 | |
| Pubmed | Rheb1 is required for mTORC1 and myelination in postnatal brain development. | 2.26e-05 | 25 | 234 | 4 | 21238928 | |
| Pubmed | Intermediate phenotypes identify divergent pathways to Alzheimer's disease. | 2.26e-05 | 25 | 234 | 4 | 20574532 | |
| Pubmed | DCAF1 KIF1B TSC1 SNX13 FCHSD2 PLCL2 ANKRD12 NEDD4L FHIP2A TENM3 BRINP2 MACF1 | 2.31e-05 | 407 | 234 | 12 | 12693553 | |
| Pubmed | 2.45e-05 | 9 | 234 | 3 | 22898830 | ||
| Pubmed | MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling. | 2.45e-05 | 9 | 234 | 3 | 25224226 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 MAP1B GTF3C4 DHX8 ARIH2 HTATSF1 KIF13B DDX17 COPZ1 COPA THUMPD3 CASP3 CPS1 EEF1G IGF2BP2 MTOR | 2.60e-05 | 704 | 234 | 16 | 29955894 |
| Pubmed | A candidate gene association study of 77 polymorphisms in migraine. | 2.65e-05 | 52 | 234 | 5 | 19559392 | |
| Pubmed | 2.70e-05 | 128 | 234 | 7 | 30995482 | ||
| Pubmed | 2.84e-05 | 129 | 234 | 7 | 23022380 | ||
| Pubmed | ITGA2 ITGA7 PLXNB2 PTPRM DLG1 MPP7 NEDD4L FCHO2 CELSR2 TENM3 MACF1 ATP2B1 | 3.21e-05 | 421 | 234 | 12 | 36976175 | |
| Pubmed | KDM4C TOGARAM1 IP6K1 CEP350 FAT2 DDHD2 PRUNE2 KIF13B ATP13A1 CDK13 MACF1 DOP1A KIF1C | 3.37e-05 | 493 | 234 | 13 | 15368895 | |
| Pubmed | Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling. | 3.48e-05 | 10 | 234 | 3 | 24656932 | |
| Pubmed | 3.48e-05 | 10 | 234 | 3 | 28414797 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MAP1B PRMT5 DLG1 NEDD4L CASP3 RHEB CELSR2 TENM3 MTOR MACF1 ATP2B1 | 3.49e-05 | 358 | 234 | 11 | 32460013 |
| Pubmed | 3.60e-05 | 28 | 234 | 4 | 20534741 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1B XAB2 DHX8 CEP350 TDRD3 URB1 SARS1 SYNJ2 COPA DICER1 IGF2BP2 AGO1 FAM193A SERPINB2 MACF1 TMEM131 | 3.64e-05 | 724 | 234 | 16 | 36232890 |
| Pubmed | MCM8 MAP1B XAB2 ITPR1 CARD6 DLG1 COG4 FHIP2A DICER1 NPLOC4 SLC4A2 CDK13 HLTF MTR SORL1 | 3.93e-05 | 650 | 234 | 15 | 38777146 | |
| Pubmed | MCM8 RCBTB2 DHX8 SMYD3 DDX17 COPZ1 COPA AGO1 CDK13 ATP2B1 MUSK | 3.95e-05 | 363 | 234 | 11 | 25036637 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 20058701 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 27031226 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 11122103 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 23415866 | ||
| Pubmed | Critical role for hypothalamic mTOR activity in energy balance. | 4.51e-05 | 2 | 234 | 2 | 19356717 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 16006564 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 26504199 | ||
| Pubmed | Caspase-7 mediated cleavage of proteasome subunits during apoptosis. | 4.51e-05 | 2 | 234 | 2 | 17880920 | |
| Pubmed | Inositol pyrophosphates regulate JMJD2C-dependent histone demethylation. | 4.51e-05 | 2 | 234 | 2 | 24191012 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 36592877 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 21911749 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 11596779 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 32068834 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 19655253 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 8898078 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 23765963 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 17696365 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 15525783 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 14550562 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 10716990 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 11834499 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 9125129 | ||
| Interaction | C2CD4B interactions | 5.81e-07 | 44 | 228 | 7 | int:C2CD4B | |
| Interaction | KIF1B interactions | KIF1A KIF1B CEP350 TDRD3 DLG1 MPP7 FHIP2B KIF13B THOC2 FHIP2A IGF2BP2 KIF1C | 6.74e-07 | 173 | 228 | 12 | int:KIF1B |
| Interaction | PSG8 interactions | 6.34e-06 | 41 | 228 | 6 | int:PSG8 | |
| Interaction | STARD13 interactions | 1.17e-05 | 68 | 228 | 7 | int:STARD13 | |
| Interaction | CD160 interactions | 1.62e-05 | 48 | 228 | 6 | int:CD160 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.41e-04 | 3 | 163 | 2 | 287 | |
| GeneFamily | Cadherin related | 4.46e-04 | 17 | 163 | 3 | 24 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.31e-04 | 18 | 163 | 3 | 1160 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 7.74e-04 | 46 | 163 | 4 | 622 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.65e-03 | 7 | 163 | 2 | 1299 | |
| GeneFamily | Immunoglobulin like domain containing | 1.86e-03 | 193 | 163 | 7 | 594 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B KDM4C TOGARAM1 KLHL20 SNX13 ITPR1 CEP350 TDRD3 FCHSD2 FAT1 MIA2 ATP11B PTPRM SYNJ2 DLG1 ALCAM GNAQ WWC1 DOCK1 FLNB DDX17 SLC11A2 ARFGEF1 THOC2 DICER1 TIPARP FAM193A CDK13 SERPINB2 HLTF MTR MACF1 TMEM131 ATP2B1 SMAD6 SOS2 | 6.83e-15 | 856 | 231 | 36 | M4500 |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN | 2.73e-07 | 50 | 231 | 7 | M5077 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | KIF1A TSC1 TLR7 RYR3 SNX13 CEP350 GGH TDRD3 UBTF PLCL2 MANF USP4 ALCAM GNAL FLNB SLC11A2 COPZ1 GLRX3 ARFGEF2 GLOD4 THOC2 BABAM2 DICER1 CDK13 MTR TRAPPC10 TMEM184C MACF1 TMEM131 SOS2 | 3.65e-07 | 1215 | 231 | 30 | M41122 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 4.45e-07 | 78 | 231 | 8 | M9814 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | TLR7 ITGA2 PPM1H RYR2 ITPR1 FCHSD2 ARIH2 SMYD3 ARFGEF1 TIPARP TTC17 | 1.77e-06 | 200 | 231 | 11 | M5679 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 9.60e-06 | 84 | 231 | 7 | M13008 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | RSF1 ITPR1 MIA2 SYNJ2 UBTF ENPP5 GNAL HOMER2 WWC1 FLNB CACNA2D1 MXRA5 DDX17 RILPL2 CCDC80 DICER1 LEPR CDK13 ERCC6L2 EPCAM SORL1 | 1.06e-05 | 807 | 231 | 21 | M16651 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.12e-05 | 157 | 231 | 9 | M7733 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | CHRNB2 FLNB CACNA2D1 NEDD4L COPA TNC IRF8 FRRS1 SERPINB2 KIF1C | 1.21e-05 | 200 | 231 | 10 | M9677 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | KIF1A MAP1B MAP2 EIF3E TOGARAM1 RCBTB2 LRRTM3 TMEM132B VWDE SARS1 PLCL2 ENPP5 ANKRD12 ALCAM PRUNE2 CACNA2D1 SLC11A2 ARFGEF2 DICER1 RHEB HLTF SORL1 | 3.62e-05 | 946 | 231 | 22 | M39169 |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 4.34e-05 | 144 | 231 | 8 | M5942 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP | TMEM132B TDRD3 PTPRM CDADC1 SMYD3 MPP7 PRUNE2 CGRRF1 UBASH3B | 5.95e-05 | 194 | 231 | 9 | M4187 |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 6.44e-05 | 196 | 231 | 9 | M8135 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | ZNF862 CEP350 ARFGEF1 DICER1 CTDSP2 CELSR2 MACF1 TTC17 SORL1 | 6.97e-05 | 198 | 231 | 9 | M7610 |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 7.14e-05 | 79 | 231 | 6 | M7102 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAP1B SNX13 CEP350 FCHSD2 FAT1 ATP11B GNAQ WWC1 FLNB ARFGEF1 TIPARP CDK13 TMEM131 ATP2B1 | 7.38e-05 | 466 | 231 | 14 | M13522 |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN | 7.52e-05 | 200 | 231 | 9 | M9659 | |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP | 7.52e-05 | 200 | 231 | 9 | M8844 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN | 7.52e-05 | 200 | 231 | 9 | M3833 | |
| Coexpression | MILI_PSEUDOPODIA | 8.60e-05 | 51 | 231 | 5 | MM824 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 9.12e-05 | 160 | 231 | 8 | M11011 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | RCBTB2 FAT1 FAT2 MIA2 GNAQ ARHGAP8 DDX17 SLC11A2 TNC ARFGEF1 GRSF1 CELSR2 MACF1 SORL1 | 1.03e-04 | 481 | 231 | 14 | M3898 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 1.12e-04 | 260 | 231 | 10 | M41075 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 1.30e-04 | 88 | 231 | 6 | M5360 | |
| Coexpression | GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 1.69e-04 | 175 | 231 | 8 | M8908 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_DN | 1.73e-04 | 59 | 231 | 5 | M12653 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.74e-04 | 32 | 231 | 4 | MM1307 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.74e-04 | 32 | 231 | 4 | M2334 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | MAP2 DGKG RYR2 RYR3 ITPR1 COL21A1 MPP7 TRMT9B PRUNE2 FLNB TNC MACF1 | 3.75e-10 | 188 | 234 | 12 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.64e-08 | 163 | 234 | 10 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.89e-08 | 173 | 234 | 10 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA2 RYR3 HOMER2 GLRX3 TNC IGF2BP2 TENM3 RGS17 UBASH3B DCBLD2 | 3.79e-08 | 178 | 234 | 10 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.18e-08 | 184 | 234 | 10 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-08 | 185 | 234 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.67e-08 | 189 | 234 | 10 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.67e-08 | 189 | 234 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | LRRTM3 RYR2 PGM5 COL21A1 PCDH15 TNC CCDC80 DNAI3 TENM3 FAM20A | 7.73e-08 | 192 | 234 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.73e-08 | 192 | 234 | 10 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Biopsy_Other_PF-Immune-Mast_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.03e-07 | 198 | 234 | 10 | 9f015553598d4c6774b2f9759e8c0f0f93e51c67 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-07 | 200 | 234 | 10 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Mast_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.13e-07 | 200 | 234 | 10 | 64bf125e0e5652a5a638a6bb32eb109cb0d5e232 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | SSTR1 CHRNB2 URB1 USH2A ITGA11 MXRA5 DNAI3 TIPARP CCDC7 TENM3 | 1.13e-07 | 200 | 234 | 10 | fe772d98c461c973dfc082e1fc50117c27ced804 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-07 | 160 | 234 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-07 | 160 | 234 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-07 | 177 | 234 | 9 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-07 | 177 | 234 | 9 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-07 | 181 | 234 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-07 | 182 | 234 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 185 | 234 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 187 | 234 | 9 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 187 | 234 | 9 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 187 | 234 | 9 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 187 | 234 | 9 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 7.41e-07 | 189 | 234 | 9 | b46adb47768a7b6d801c457d7ba65508edfc36a5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-07 | 189 | 234 | 9 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.41e-07 | 189 | 234 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.75e-07 | 190 | 234 | 9 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-07 | 190 | 234 | 9 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-07 | 190 | 234 | 9 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 8.10e-07 | 191 | 234 | 9 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-07 | 191 | 234 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-07 | 191 | 234 | 9 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-07 | 192 | 234 | 9 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-07 | 192 | 234 | 9 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-07 | 192 | 234 | 9 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-07 | 192 | 234 | 9 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-07 | 193 | 234 | 9 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-07 | 194 | 234 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-07 | 195 | 234 | 9 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 9.62e-07 | 195 | 234 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 197 | 234 | 9 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.14e-06 | 199 | 234 | 9 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.14e-06 | 199 | 234 | 9 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.19e-06 | 200 | 234 | 9 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-06 | 200 | 234 | 9 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.19e-06 | 200 | 234 | 9 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-06 | 200 | 234 | 9 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 2.58e-06 | 164 | 234 | 8 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 3.37e-06 | 170 | 234 | 8 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.37e-06 | 170 | 234 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 170 | 234 | 8 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.18e-06 | 175 | 234 | 8 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-06 | 180 | 234 | 8 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.14e-06 | 180 | 234 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.36e-06 | 181 | 234 | 8 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-06 | 182 | 234 | 8 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-06 | 182 | 234 | 8 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-06 | 182 | 234 | 8 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-06 | 182 | 234 | 8 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.81e-06 | 183 | 234 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.81e-06 | 183 | 234 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 184 | 234 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-06 | 184 | 234 | 8 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 184 | 234 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 184 | 234 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.05e-06 | 184 | 234 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 184 | 234 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 186 | 234 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.55e-06 | 186 | 234 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.81e-06 | 187 | 234 | 8 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.81e-06 | 187 | 234 | 8 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-06 | 188 | 234 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.36e-06 | 189 | 234 | 8 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-06 | 189 | 234 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | normal_Lung-MAST_cells|normal_Lung / Location, Cell class and cell subclass | 7.36e-06 | 189 | 234 | 8 | f09e387dc0626536050cd537dda212471a7267c4 | |
| ToppCell | normal_Lung-MAST_cells-MAST|normal_Lung / Location, Cell class and cell subclass | 7.36e-06 | 189 | 234 | 8 | fd053209034fca6eaefe0e5ad024ac4548a100c9 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.65e-06 | 190 | 234 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-06 | 190 | 234 | 8 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 234 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 234 | 8 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 191 | 234 | 8 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 191 | 234 | 8 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.95e-06 | 191 | 234 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 234 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.26e-06 | 192 | 234 | 8 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.26e-06 | 192 | 234 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.26e-06 | 192 | 234 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.58e-06 | 193 | 234 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 193 | 234 | 8 | 5da60321bcf761913eb30779b6d8b1e933c5e51e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.58e-06 | 193 | 234 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.58e-06 | 193 | 234 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.58e-06 | 193 | 234 | 8 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 193 | 234 | 8 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| Drug | 8-amino-cADPR | 4.24e-08 | 11 | 228 | 5 | CID003081323 | |
| Drug | XeC compound | 1.66e-07 | 84 | 228 | 9 | CID000005701 | |
| Drug | mecobalamin | 9.91e-07 | 3 | 228 | 3 | ctd:C019476 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.27e-06 | 79 | 228 | 8 | CID005287890 | |
| Drug | phenytoin | MAP1B MAP2 ITGA2 PLXNB2 RYR2 RYR3 ITPR1 GGH NFKB2 SCN4A SCN5A CACNA2D1 | 2.30e-06 | 219 | 228 | 12 | CID000001775 |
| Drug | NAADP | 2.34e-06 | 39 | 228 | 6 | CID000123952 | |
| Drug | fura 2 | 3.91e-06 | 65 | 228 | 7 | CID000057054 | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | MAP1B CHN2 CEP350 MIA2 CDADC1 DOCK1 DDX17 SLC11A2 BABAM2 DOP1A SORL1 | 4.87e-06 | 196 | 228 | 11 | 6571_DN |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | KIF1B CD84 UBTF NFKB2 CDADC1 FHIP2B DDX17 SLC11A2 ARFGEF1 TRAPPC10 SOS2 | 4.87e-06 | 196 | 228 | 11 | 1182_DN |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | CHRNB2 ITPR1 TDRD3 URB1 MIA2 PTPRS ARIH2 DOCK1 VIPR2 CDK13 DOP1A | 5.11e-06 | 197 | 228 | 11 | 3247_UP |
| Drug | 2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide | 6.52e-06 | 13 | 228 | 4 | ctd:C561454 | |
| Drug | indo-1 | 7.00e-06 | 99 | 228 | 8 | CID000105060 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | PPM1H FCHSD2 PLCL2 ANKRD12 WWC1 NEDD4L ARFGEF1 CDK13 ATP2B1 SOS2 | 9.21e-06 | 171 | 228 | 10 | 7535_DN |
| Drug | Ac-DNLD-Cho | 9.77e-06 | 5 | 228 | 3 | CID010458686 | |
| Drug | Gvapspat amide | 1.23e-05 | 15 | 228 | 4 | CID000125015 | |
| Drug | chloro-m-cresol | 1.94e-05 | 6 | 228 | 3 | CID000012008 | |
| Drug | MBED | 1.94e-05 | 6 | 228 | 3 | CID000129958 | |
| Drug | Alsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A | GTPBP4 MIA2 SYNJ2 COL21A1 GNAL COPA GLRX3 BABAM2 TIPARP SERPINB2 | 2.41e-05 | 191 | 228 | 10 | 7078_UP |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.74e-05 | 155 | 228 | 9 | 6817_DN | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | ZNF862 TBC1D2 RCBTB2 CD84 MIA2 IMPG2 SLC11A2 DICER1 LEPR TIPARP | 2.75e-05 | 194 | 228 | 10 | 2828_UP |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.75e-05 | 194 | 228 | 10 | 3900_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; HL60; HT_HG-U133A | TBC1D2 TOGARAM1 RCBTB2 TDRD3 ARIH2 HTATSF1 CPVL DDX17 CDK13 ATP2B1 | 3.00e-05 | 196 | 228 | 10 | 1852_UP |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.14e-05 | 197 | 228 | 10 | 2259_DN | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A | GTPBP4 KDM4C RYR2 ITPR1 MIA2 SYNJ2 PTPRS SLC11A2 GLRX3 TRAPPC10 | 3.14e-05 | 197 | 228 | 10 | 2304_DN |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.14e-05 | 197 | 228 | 10 | 2277_DN | |
| Drug | 4-chloro-m-cresol | 3.24e-05 | 37 | 228 | 5 | CID000001732 | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A | GTF3C4 KLHL20 ITPR1 ATP11B SLC11A2 GLRX3 ARFGEF2 ARFGEF1 TMEM184C TTC17 | 3.27e-05 | 198 | 228 | 10 | 1619_DN |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | TBC1D2 CHRNB2 SNX13 SYNJ2 PLCL2 GNAL CACNA2D1 CDK13 CUZD1 ELL | 3.27e-05 | 198 | 228 | 10 | 2638_UP |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 3.27e-05 | 198 | 228 | 10 | 6189_DN | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; HL60; HG-U133A | KLHL20 CHRNB2 CD84 UBTF SLC11A2 COPZ1 COPA GLRX3 ARFGEF1 TMEM184C | 3.27e-05 | 198 | 228 | 10 | 1407_DN |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 3.37e-05 | 7 | 228 | 3 | CID009547999 | |
| Drug | Azumoleno | 3.37e-05 | 7 | 228 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 3.37e-05 | 7 | 228 | 3 | CID003081001 | |
| Drug | CHEBI:564108 | 3.37e-05 | 7 | 228 | 3 | CID006400637 | |
| Drug | dihydromyricetin | 3.37e-05 | 19 | 228 | 4 | ctd:C472036 | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 228 | 10 | 4950_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A | MAP1B RCBTB2 CHN2 TDRD3 SYNJ2 DICER1 ZNF783 CDK13 DOP1A SOS2 | 3.57e-05 | 200 | 228 | 10 | 4475_DN |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A | TBC1D2 RCBTB2 KLHL20 SNX13 FPR2 BABAM2 LEPR ZNF783 CDK13 SOS2 | 3.57e-05 | 200 | 228 | 10 | 3584_UP |
| Drug | AC1L98DX | 3.70e-05 | 38 | 228 | 5 | CID000439957 | |
| Drug | AC1MMLID | 3.92e-05 | 92 | 228 | 7 | CID000013245 | |
| Drug | bepridil | 4.08e-05 | 126 | 228 | 8 | CID000002351 | |
| Drug | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | 4.69e-05 | 166 | 228 | 9 | ctd:C036990 | |
| Drug | dipyrone | 4.77e-05 | 40 | 228 | 5 | CID000003110 | |
| Drug | lead chromate | 5.88e-05 | 98 | 228 | 7 | CID000024460 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | DGKG IP6K1 ACE RYR2 RYR3 ITPR1 MS4A2 PLCL2 GNAQ HOMER2 VIPR2 CACNA2D1 FPR2 MTOR B4GALNT2 ATP2B1 SOS2 | 6.38e-05 | 568 | 228 | 17 | CID000000806 |
| Drug | tBuBHQ | 6.69e-05 | 69 | 228 | 6 | CID000002374 | |
| Drug | AC1L2AC7 | 6.69e-05 | 69 | 228 | 6 | CID000068733 | |
| Drug | 1-Butanol | 7.25e-05 | 70 | 228 | 6 | ctd:D020001 | |
| Drug | p-toluenesulfinic acid | 7.47e-05 | 23 | 228 | 4 | CID000010818 | |
| Drug | p-toluidine | 7.86e-05 | 71 | 228 | 6 | CID000007813 | |
| Drug | benzathine | 7.96e-05 | 9 | 228 | 3 | CID000008793 | |
| Drug | ApApA | 7.96e-05 | 9 | 228 | 3 | CID000097495 | |
| Drug | AP-A | 8.89e-05 | 24 | 228 | 4 | CID000188964 | |
| Drug | 4-chlorophenol | 8.89e-05 | 24 | 228 | 4 | CID000004684 | |
| Drug | Theophylline | TPP2 KIF1B EIF3E SNX13 DHX8 TYR FCHSD2 UBTF DLG1 C5 GNAQ NEDD4L GLRX3 CASP3 BABAM2 CDK13 | 9.93e-05 | 532 | 228 | 16 | ctd:D013806 |
| Drug | NSC304666 | 9.98e-05 | 2 | 228 | 2 | CID000003886 | |
| Drug | Flecainide | 9.98e-05 | 2 | 228 | 2 | DB01195 | |
| Drug | theogallin | 9.98e-05 | 2 | 228 | 2 | CID000442988 | |
| Drug | 4-(6-hydroxy-2-naphthyl)-1,3-benzenediol | 9.98e-05 | 2 | 228 | 2 | ctd:C523393 | |
| Drug | diisopropylfluorophosphate | TPP2 MASP1 ACE F5 GGH FAP CPVL PLA2G4E SLC4A2 PREP SERPINB2 ENPEP | 1.02e-04 | 321 | 228 | 12 | CID000005936 |
| Drug | phosphine oxide | 1.03e-04 | 107 | 228 | 7 | CID000166931 | |
| Drug | MgSO4.7H2O | 1.05e-04 | 25 | 228 | 4 | CID000024843 | |
| Drug | PCB 95 | 1.13e-04 | 10 | 228 | 3 | CID000038012 | |
| Drug | BO-1051 | 1.13e-04 | 10 | 228 | 3 | ctd:C557045 | |
| Drug | Bentonite | 1.13e-04 | 10 | 228 | 3 | ctd:D001546 | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.17e-04 | 187 | 228 | 9 | 7368_UP | |
| Drug | Alsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A | 1.22e-04 | 188 | 228 | 9 | 7056_UP | |
| Drug | AC1L1GTT | 1.28e-04 | 233 | 228 | 10 | CID000003837 | |
| Drug | Cocaine | MAP1B MAP2 EIF3E SSTR1 ACE PLXNB2 CHRNB2 RYR2 RYR3 ITPR1 COL21A1 UBTF NFKB2 SYN1 ENPP5 FGD5 ALCAM HOMER2 DRP2 NEDD4L GLRX3 CASP3 TF DICER1 EEF1G TENM3 MUSK SORL1 | 1.35e-04 | 1314 | 228 | 28 | ctd:D003042 |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.38e-04 | 191 | 228 | 9 | 4273_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | PPM1H SYNJ2 NFKB2 HOMER2 KIF13B DDX17 SLC11A2 CDK13 SERPINB2 | 1.38e-04 | 191 | 228 | 9 | 7379_DN |
| Drug | Fura-2AM | 1.43e-04 | 79 | 228 | 6 | CID000105091 | |
| Drug | C x B | 1.43e-04 | 27 | 228 | 4 | CID009600412 | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.49e-04 | 193 | 228 | 9 | 6730_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 228 | 9 | 6215_DN | |
| Drug | peonidin-3-glucoside | 1.54e-04 | 11 | 228 | 3 | CID000443654 | |
| Drug | R 478 | 1.54e-04 | 11 | 228 | 3 | CID000084223 | |
| Drug | phenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA | 1.55e-04 | 194 | 228 | 9 | 1115_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.55e-04 | 194 | 228 | 9 | 3774_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.61e-04 | 195 | 228 | 9 | 3580_DN | |
| Drug | CH2Cl | 1.66e-04 | 28 | 228 | 4 | CID005378701 | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 228 | 9 | 4591_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 228 | 9 | 6678_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.67e-04 | 196 | 228 | 9 | 1054_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 228 | 9 | 4644_UP | |
| Drug | Gleevec; Up 200; 10uM; PC3; HG-U133A | 1.67e-04 | 196 | 228 | 9 | 483_UP | |
| Drug | lamotrigine | 1.70e-04 | 116 | 228 | 7 | CID000003878 | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 6106_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 4625_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 2285_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 2133_DN | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 1693_UP | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 7551_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 3196_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 1695_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 5482_DN | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 197 | 228 | 9 | 7228_UP | |
| Drug | cADPR | 1.75e-04 | 82 | 228 | 6 | CID000123847 | |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | 1.81e-04 | 198 | 228 | 9 | 6388_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.81e-04 | 198 | 228 | 9 | 3842_UP | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 8.72e-06 | 6 | 226 | 3 | DOID:0050454 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 1.52e-05 | 7 | 226 | 3 | C1868720 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.62e-05 | 154 | 226 | 8 | EFO_0001645, EFO_0004623 | |
| Disease | energy expenditure | 5.12e-05 | 27 | 226 | 4 | EFO_0005109 | |
| Disease | Malignant neoplasm of breast | DGKG MIA2 SYNJ2 FGD5 KIT FLNB PCDHB15 IRF8 ARFGEF2 CASP7 UGT1A9 LEPR ZNF532 MTOR SERPINB2 MTR MACF1 ENPEP FLACC1 DOP1A SORL1 | 8.77e-05 | 1074 | 226 | 21 | C0006142 |
| Disease | nervous system disease (implicated_via_orthology) | 9.27e-05 | 12 | 226 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | psychosis | 1.52e-04 | 14 | 226 | 3 | EFO_0005407 | |
| Disease | anemia (is_implicated_in) | 1.52e-04 | 14 | 226 | 3 | DOID:2355 (is_implicated_in) | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.65e-04 | 67 | 226 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.74e-04 | 3 | 226 | 2 | C0349788 | |
| Disease | Isolated focal cortical dysplasia type II | 1.74e-04 | 3 | 226 | 2 | cv:C1846385 | |
| Disease | Retinal Vein Occlusion | 1.74e-04 | 3 | 226 | 2 | C0035328 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.74e-04 | 3 | 226 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.74e-04 | 3 | 226 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIb | 1.74e-04 | 3 | 226 | 2 | C1846389 | |
| Disease | FOCAL CORTICAL DYSPLASIA OF TAYLOR | 1.74e-04 | 3 | 226 | 2 | C1846385 | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIa | 1.74e-04 | 3 | 226 | 2 | C1846386 | |
| Disease | Thrombosis of retinal vein | 1.74e-04 | 3 | 226 | 2 | C1527411 | |
| Disease | intermittent claudication (implicated_via_orthology) | 1.74e-04 | 3 | 226 | 2 | DOID:3669 (implicated_via_orthology) | |
| Disease | FOCAL CORTICAL DYSPLASIA, TYPE II | 1.74e-04 | 3 | 226 | 2 | 607341 | |
| Disease | quinate measurement | 1.88e-04 | 15 | 226 | 3 | EFO_0021167 | |
| Disease | lipoprotein A measurement | 2.30e-04 | 112 | 226 | 6 | EFO_0006925 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.31e-04 | 16 | 226 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | blood nickel measurement | 3.34e-04 | 120 | 226 | 6 | EFO_0007583 | |
| Disease | Inherited acute myeloid leukemia | 3.47e-04 | 4 | 226 | 2 | C4707228 | |
| Disease | Male Germ Cell Tumor | 3.47e-04 | 4 | 226 | 2 | C3496549 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 3.47e-04 | 4 | 226 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.49e-04 | 121 | 226 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | COVID-19, mortality | 3.52e-04 | 170 | 226 | 7 | EFO_0004352, MONDO_0100096 | |
| Disease | mean corpuscular hemoglobin concentration | MAG PPM1H SNX13 ZGPAT ATP11B UBTF PLCL2 ANKRD12 IMPG2 SLC11A2 ARFGEF2 CPS1 FCHO2 TF LEPR NPLOC4 SLC4A2 MACF1 MUSK ELL | 3.54e-04 | 1105 | 226 | 20 | EFO_0004528 |
| Disease | calcium measurement | ITPR1 GGH UBTF GNAQ FHIP2B COPZ1 CPS1 FCHO2 CELSR2 EBLN1 MACF1 TMEM131 UBASH3B ATP2B1 | 3.77e-04 | 628 | 226 | 14 | EFO_0004838 |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 3.90e-04 | 45 | 226 | 4 | DOID:3525 (implicated_via_orthology) | |
| Disease | alpha-tocopherol measurement | 4.59e-04 | 20 | 226 | 3 | EFO_0007898 | |
| Disease | end stage renal disease (implicated_via_orthology) | 4.59e-04 | 20 | 226 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | Schizophrenia | MAG LAMA1 ACE CHRNB2 TYR PLCL2 SYN1 DLG1 GNAL HOMER2 VIPR2 CASP3 TF DICER1 IGF2BP2 MTOR MTR | 4.97e-04 | 883 | 226 | 17 | C0036341 |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 5.75e-04 | 5 | 226 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | tuberous sclerosis (implicated_via_orthology) | 5.75e-04 | 5 | 226 | 2 | DOID:13515 (implicated_via_orthology) | |
| Disease | endometritis (biomarker_via_orthology) | 5.75e-04 | 5 | 226 | 2 | DOID:1002 (biomarker_via_orthology) | |
| Disease | Usher Syndrome, Type II | 5.75e-04 | 5 | 226 | 2 | C1568249 | |
| Disease | Sudden death | 5.75e-04 | 5 | 226 | 2 | C0011071 | |
| Disease | Granulosa Cell Cancer | 5.75e-04 | 5 | 226 | 2 | C1567257 | |
| Disease | cholelithiasis | 5.89e-04 | 88 | 226 | 5 | EFO_0004799 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 6.32e-04 | 51 | 226 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Uterine leiomyoma | 6.87e-04 | 91 | 226 | 5 | HP_0000131 | |
| Disease | hemoglobin A1 measurement | DCAF1 ATP11B USP4 COPZ1 IGF2BP2 MACF1 RGS17 UBASH3B FLACC1 MUSK KIF1C SOS2 | 7.28e-04 | 520 | 226 | 12 | EFO_0007629 |
| Disease | ascending aortic diameter | 7.55e-04 | 140 | 226 | 6 | EFO_0021787 | |
| Disease | Albuminuria | 7.97e-04 | 24 | 226 | 3 | C0001925 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 7.97e-04 | 24 | 226 | 3 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.97e-04 | 195 | 226 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Ischemic stroke, fibrinogen measurement | 8.42e-04 | 55 | 226 | 4 | EFO_0004623, HP_0002140 | |
| Disease | iron deficiency anemia (is_implicated_in) | 8.58e-04 | 6 | 226 | 2 | DOID:11758 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | TDRD15 VWDE SNX13 ITPR1 SYNJ2 UGT2B17 COG4 NEDD4L ATP13A1 CPS1 FCHO2 FHIP2A BABAM2 LEPR MACF1 UBASH3B DCBLD2 MUSK | 8.82e-04 | 1015 | 226 | 18 | EFO_0004533 |
| Disease | apolipoprotein A 1 measurement | DGKG SNX13 SARS1 MUC17 ALCAM KIT CPS1 TF LEPR CELSR2 MACF1 RGS17 UBASH3B MUSK ELL SORL1 | 8.96e-04 | 848 | 226 | 16 | EFO_0004614 |
| Disease | cortical thickness | EXD1 NUP210L LAMA1 STMN4 COL21A1 UBTF ALCAM CPVL HOMER2 TRMT9B FLNB COX7A2 ARFGEF2 GLOD4 MACF1 TMEM131 MUSK ELL SOS2 | 9.97e-04 | 1113 | 226 | 19 | EFO_0004840 |
| Disease | fibrinogen measurement, factor VII measurement | 1.03e-03 | 58 | 226 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.05e-03 | 100 | 226 | 5 | C0276496 | |
| Disease | Vitiligo | 1.10e-03 | 101 | 226 | 5 | EFO_0004208 | |
| Disease | Alzheimer's Disease | 1.10e-03 | 101 | 226 | 5 | C0002395 | |
| Disease | hypertension, COVID-19 | 1.13e-03 | 27 | 226 | 3 | EFO_0000537, MONDO_0100096 | |
| Disease | retinal vein occlusion (is_implicated_in) | 1.20e-03 | 7 | 226 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | Calcium channel blocker use measurement | 1.33e-03 | 213 | 226 | 7 | EFO_0009930 | |
| Disease | longevity, healthspan, parental longevity | 1.40e-03 | 29 | 226 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | Parkinsonism (implicated_via_orthology) | 1.40e-03 | 29 | 226 | 3 | DOID:0080855 (implicated_via_orthology) | |
| Disease | gallstones | 1.48e-03 | 108 | 226 | 5 | EFO_0004210 | |
| Disease | Malignant mesothelioma | 1.54e-03 | 109 | 226 | 5 | C0345967 | |
| Disease | fibrinogen measurement | 1.54e-03 | 109 | 226 | 5 | EFO_0004623 | |
| Disease | Epileptic encephalopathy | 1.55e-03 | 30 | 226 | 3 | C0543888 | |
| Disease | intellectual disability (is_implicated_in) | 1.55e-03 | 30 | 226 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.59e-03 | 8 | 226 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | obsolete_red blood cell distribution width | MAG TPP2 PPM1H SNX13 ZGPAT ATP11B MUC17 PLCL2 USP4 ANKRD12 GNAQ COPZ1 CPS1 FCHO2 TF GRSF1 NPLOC4 IGF2BP2 MUSK ELL SMAD6 | 1.68e-03 | 1347 | 226 | 21 | EFO_0005192 |
| Disease | factor VIII measurement, coronary artery disease | 1.81e-03 | 113 | 226 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.96e-03 | 228 | 226 | 7 | EFO_0003948, MONDO_0004975 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.96e-03 | 69 | 226 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | pre-malignant neoplasm (implicated_via_orthology) | 2.03e-03 | 9 | 226 | 2 | DOID:0060071 (implicated_via_orthology) | |
| Disease | symmetrical dimethylarginine measurement | 2.03e-03 | 9 | 226 | 2 | EFO_0006523 | |
| Disease | Chronic schizophrenia | 2.03e-03 | 9 | 226 | 2 | C0221765 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 2.03e-03 | 9 | 226 | 2 | EFO_0800314 | |
| Disease | hematocrit | TDRD15 EXD1 FRMD7 KIF1B ITPR1 ZGPAT FAT1 PLCL2 FGD5 CACNA2D1 DDX17 COPZ1 SLC4A2 CTDSP2 MUSK ELL SMAD6 | 2.14e-03 | 1011 | 226 | 17 | EFO_0004348 |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.19e-03 | 118 | 226 | 5 | EFO_0010119 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.19e-03 | 118 | 226 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | factor VIII measurement, venous thromboembolism | 2.23e-03 | 34 | 226 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.44e-03 | 121 | 226 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.52e-03 | 10 | 226 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.52e-03 | 10 | 226 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 3-phenylpropionate hydrocinnamate measurement | 2.52e-03 | 10 | 226 | 2 | EFO_0021010 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 2.52e-03 | 10 | 226 | 2 | cv:CN043592 | |
| Disease | high density lipoprotein cholesterol measurement, multiple sclerosis | 2.52e-03 | 10 | 226 | 2 | EFO_0004612, MONDO_0005301 | |
| Disease | skin neoplasm | 2.54e-03 | 74 | 226 | 4 | EFO_0004198 | |
| Disease | total blood protein measurement | SNX13 USP4 IMPG2 CACNA2D1 CPS1 TF MACF1 TMEM131 UBASH3B MUSK | 2.57e-03 | 449 | 226 | 10 | EFO_0004536 |
| Disease | creatine measurement | 2.63e-03 | 36 | 226 | 3 | EFO_0010472 | |
| Disease | Behcet's disease (is_implicated_in) | 2.63e-03 | 36 | 226 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 2.66e-03 | 75 | 226 | 4 | EFO_0007006, EFO_0009262 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.79e-03 | 181 | 226 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Cognitive impairment | 3.07e-03 | 11 | 226 | 2 | HP_0100543 | |
| Disease | Long QT Syndrome | 3.07e-03 | 11 | 226 | 2 | C0023976 | |
| Disease | Tachycardia, Ventricular | 3.07e-03 | 11 | 226 | 2 | C0042514 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.07e-03 | 11 | 226 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | obstructive sleep apnea (is_implicated_in) | 3.07e-03 | 11 | 226 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | melanoma | 3.13e-03 | 248 | 226 | 7 | C0025202 | |
| Disease | Colorectal Carcinoma | MAP1B MAP2 LAMA1 F5 GGH FAT1 CFAP77 PTPRS SLC11A2 ARFGEF1 RHEB B4GALNT2 SORL1 | 3.14e-03 | 702 | 226 | 13 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFSYKPYVQEAEEGS | 311 | Q9NVA4 | |
| QTLIYYVDEKAPEFS | 246 | P16422 | |
| ELNIYSATYSELEDP | 221 | Q01362 | |
| DYSIEDTYTQKLSVP | 951 | P04920 | |
| GSVYFISVYDKESPQ | 451 | Q8NDM7 | |
| QITIFTDYLEEYPDT | 11 | Q8WYN0 | |
| TPDYLLKYAAISSSE | 506 | P55199 | |
| YSVYDSSAVQKVIPS | 76 | Q6ZQR2 | |
| NLSPFENKEETYEYS | 1291 | Q96M83 | |
| KPLYEDFTALSNEAY | 201 | P12821 | |
| YYPDLTVIVADDSQK | 346 | Q8NHY0 | |
| AEFKASLSPVIYDSL | 661 | Q9H9E3 | |
| DSKDLPEEYLSAIYN | 861 | Q9Y6D6 | |
| YKEFEPSLVNSTVYI | 1091 | Q9HD20 | |
| LSPSVEKYRYQDEDT | 101 | Q12959 | |
| ADVDVQPYAFTTKSL | 191 | Q9BZE4 | |
| ASTTDLRVDYKYNPE | 681 | Q0JRZ9 | |
| DVSATAFYKAQPVIE | 216 | Q9UL18 | |
| DSKDLPEEYLSSIYE | 806 | Q9Y6D5 | |
| FSSEIDQYQKYLPDI | 2186 | Q5JWR5 | |
| PEEYQFTCLTYKESE | 56 | O95376 | |
| ITKTLPDANTDFYYE | 216 | Q9BWV3 | |
| LDVVSPLDYETTKEY | 456 | Q9HCU4 | |
| TAYAIYELAVASFPK | 66 | P14406 | |
| DPATYKSISIYEIQE | 2031 | Q6UB98 | |
| YVADVYTDLTPLSKF | 946 | Q9UPY3 | |
| KNATTQYYPREFSEE | 251 | Q8IWG1 | |
| KIPVEADFLYAYSTA | 186 | P42574 | |
| EYLTNKTEEYTEQPE | 41 | Q6ZUS5 | |
| LYSSEESRPYTNKVI | 861 | Q14004 | |
| ADIYPLSNYDDTEVV | 306 | P78312 | |
| DYYLQVSLKAPEATV | 261 | Q8N5I2 | |
| EIPEEALYKVYTFNS | 566 | P20020 | |
| YEEKYDLSRPTASQL | 506 | Q76M96 | |
| EYLYTDSISLSPEEA | 446 | O95199 | |
| PQVETKTEFAYEYVL | 26 | Q52LD8 | |
| IYEDYISILSPKEVS | 136 | Q9UGC6 | |
| DFIQVPVSAEDKSYR | 461 | Q7Z3E1 | |
| STKYYLNDLDRVADP | 156 | P50148 | |
| SYSQESKTTYLEDLP | 116 | Q12849 | |
| YSVAKTDSFEYVDPV | 471 | Q15124 | |
| DQDVYDTLTYSLDPQ | 3571 | Q14517 | |
| ADKVSVTYYGPNEDA | 96 | Q6TGC4 | |
| TFNATDYKPIATIDV | 1336 | Q9Y4B6 | |
| ESSLYSQEYSKPADV | 1166 | P46821 | |
| YSYETTEKITSFPES | 2006 | P46821 | |
| PTKDSYTLTEELAEY | 606 | P20916 | |
| YFSEVYSDSSPLIEK | 81 | Q9UJA3 | |
| YSDSSPLIEKIQAFE | 86 | Q9UJA3 | |
| EETNKSFYEVINVSP | 71 | Q96Q35 | |
| SNLSYYVEVTDKPFS | 166 | Q2M2H8 | |
| DYPKSENESNIRYVS | 361 | P10721 | |
| VKVKDSTEYTGPESY | 2656 | Q14643 | |
| SASIFSEVRYVKEPY | 161 | Q8NE63 | |
| YYDPFEQLDSELQSK | 466 | Q8IX03 | |
| DYTRITEDSFSKPYD | 51 | Q9HC38 | |
| VSEKYEISSVPTFLF | 76 | O76003 | |
| STPLNEYEEVSYESA | 6 | P25090 | |
| PYVEDLSKLAVTSYT | 176 | O60333 | |
| ENLPYEEEIYKDSST | 91 | Q9HCE5 | |
| PASKQAVTVSYFYDV | 26 | Q9NSB8 | |
| LKYSPSEEEEVTYTV | 66 | Q8NHP7 | |
| SDSESEILKPDYYAL | 651 | Q6ZUT3 | |
| TEPEDQLYYVKFLSL | 321 | Q9H3G5 | |
| PTLESINYDSETYDA | 21 | Q99645 | |
| TPDSDKNKTYSVEYL | 306 | O75369 | |
| LKVYLTPDGTSSEYD | 416 | O15031 | |
| TIYENSSPKTYVESF | 41 | Q9NYQ8 | |
| YYIESTDESTPAKKT | 36 | Q86V87 | |
| TDRSQLDISEPYKVY | 96 | Q02556 | |
| EDIYVASTPDYSVDN | 211 | A8MYZ0 | |
| PYNESVSFEDRVAKI | 156 | Q9UJA9 | |
| ADQDAESAYTEPYKV | 836 | Q6ZNL6 | |
| YAKESSSEQYVPDVF | 411 | Q8TAT6 | |
| SSEQYVPDVFYKDVD | 416 | Q8TAT6 | |
| KKSDQYDTADVPTYE | 341 | Q5T2T1 | |
| YDDTYPSVKEQKAFE | 31 | P61923 | |
| VPYSESFSQVLEETY | 126 | O94830 | |
| PYVQDLSKLAVTSYA | 176 | O43896 | |
| TEDDKAYAYRSVPSI | 466 | Q9H3R0 | |
| LSSRFKNEYVADPVY | 1026 | Q9H3R0 | |
| YEVYDAKSKSVSLPV | 586 | P48357 | |
| KYDLILTSETIYNPD | 286 | O95568 | |
| YFATYFNEKISIPEE | 46 | P49281 | |
| TYRETNLLYDPKESA | 366 | Q07075 | |
| ENYSFKISYIPDEEV | 146 | Q9Y6M1 | |
| DYVKPVTFSVEYSLE | 741 | Q9UKX5 | |
| EATYLELASAVKEQY | 36 | Q9BRT3 | |
| LYYSSQEIDKPFELS | 281 | Q9Y5E8 | |
| LEAYSETAKVFSIPF | 771 | P17301 | |
| PQERYSEEQKAYFST | 211 | Q9Y4U1 | |
| PTYVEYSEQTDVLRK | 381 | Q6P4A8 | |
| YQDLKDRDVTFSPAT | 41 | P55145 | |
| PDEKSVITYVSSIYD | 281 | Q9UPN3 | |
| TTSYVVEDLKPNTEY | 576 | Q13332 | |
| PKITEDFIATYQANY | 61 | O43719 | |
| DYIKSIAPITDFEYS | 116 | P38405 | |
| FVDSYDPTIENTFTK | 31 | Q15382 | |
| DASDYQTVQIFYPSK | 431 | P48147 | |
| TPYATKELTYTEATF | 816 | Q3MJ16 | |
| EDYTKCDLTVYAIDP | 1301 | Q96QU1 | |
| IPVITYDTYSKFIDA | 361 | P52757 | |
| PEEFDQLQKYSEYSS | 11 | P49619 | |
| LYASKFEDVLPTFTA | 116 | P0CF75 | |
| TLNEALEFAKSVDYP | 1111 | P31327 | |
| AEYKLEFVPTTTTEY | 716 | Q9C0G6 | |
| TYLKTIEVFDPDANT | 566 | Q9Y2M5 | |
| YSLISSPEITENYLD | 231 | Q8NFQ6 | |
| EKEYDTPEVTLSYSV | 166 | Q9BX69 | |
| LYDPVESKFISENYL | 246 | Q14185 | |
| SFEDTEATQVYPKLY | 206 | Q9NXR7 | |
| KDIYLVEYSLSTSPF | 41 | Q9P109 | |
| EEEKALIYQFSPIYT | 291 | Q92820 | |
| PETYEDSFYKRSLDN | 756 | P54289 | |
| LFTASLAKYADPVTD | 161 | O14595 | |
| LENSTYDLYTIPKDA | 386 | P53621 | |
| LITYEKYDVTDSPKN | 346 | Q6ZNA5 | |
| QTSSDPDVLEYYKND | 71 | Q2WGN9 | |
| YTEAFDATISIKSYP | 46 | P01031 | |
| ELDYQDPDATSLKYV | 706 | Q86WJ1 | |
| KDVSEYFYEKSLPSV | 2606 | Q5VT06 | |
| YFYEKSLPSVNDIEA | 2611 | Q5VT06 | |
| AIANKPSSTYVFYVE | 181 | Q96P44 | |
| SQTYEVFEKDPIKYS | 321 | O14744 | |
| IQQESYTYKDPITEF | 281 | P60228 | |
| YKIPVEADFLFAYST | 211 | P55210 | |
| LTYLYFSAVDPIKDT | 536 | Q6MZM0 | |
| YPKSSECLYTIELEE | 206 | P48740 | |
| LVAYPYVESETVEQD | 91 | Q92551 | |
| YLPSEIRSSKIDDNY | 11 | A0A1B0GTZ2 | |
| SYSPTVALDYVLDAD | 561 | Q13683 | |
| KYSNEDTLSVALPYF | 296 | P26641 | |
| LDTASNFLEPEFSKY | 196 | Q96PD2 | |
| DVKFVINYDYPNSSE | 486 | Q92841 | |
| YYNTITNFSEKDRPE | 271 | Q14527 | |
| ESNSFEKTILESPYY | 401 | Q86UP6 | |
| SQYPEVKEFFVDSVS | 1276 | Q5T890 | |
| VVYSYKASQPDELTI | 476 | O94868 | |
| YYIETSDDKAPVTDT | 36 | Q5W0V3 | |
| STPQALEDALYSEYL | 121 | Q99675 | |
| ETKFYETKEESYSPS | 461 | Q96T23 | |
| ELSTYYQVEPSTKLF | 1526 | Q92736 | |
| KTIHSEQAVFDIYYP | 231 | Q13740 | |
| DVAYEKKPSQTASYE | 256 | Q8WUF5 | |
| KSPFQLTAEDVYDIS | 31 | Q969X0 | |
| YLPVQSVLEADYSET | 691 | Q13474 | |
| ILYTKEPETDYLDAS | 746 | Q14562 | |
| PYVEDLSKLAVTSYN | 176 | Q12756 | |
| YLESSATFAAYEPLK | 641 | Q5VU65 | |
| YEITYKAVSSFDPEI | 516 | P28827 | |
| QKYYSSEPQAVDFLE | 146 | P05120 | |
| YATYESTLFEDQVPA | 166 | Q96PC5 | |
| ESTIPKVLQYYSAAT | 1766 | P42345 | |
| KYTPEYKTVLDNATE | 4256 | Q685J3 | |
| PASADSEAYIEKYLR | 1331 | Q9NQT8 | |
| NSYDEKYLIATSEQP | 261 | P49591 | |
| ALTKTYATAEPFIDA | 296 | P17600 | |
| YEQYLSEKASPRVTV | 446 | Q9Y5W8 | |
| ASLSYEVSDLQPYTE | 2491 | O75445 | |
| AAEEPVDYYATALKS | 346 | P30872 | |
| SPESAEEYIEYLKSS | 176 | Q9HCS7 | |
| EDDNTILYAYETKPE | 21 | Q9UN30 | |
| ALARPKSSDVYVSYD | 126 | Q92673 | |
| YDSPDQDLLYAVAVK | 1956 | Q92673 | |
| PTLSANEESLYYIEE | 36 | Q07890 | |
| GKRESQTSIPDYFYD | 441 | Q9H7E2 | |
| FLVTADPKSENIYDY | 1726 | Q8WUY3 | |
| DPKSENIYDYLDSSE | 1731 | Q8WUY3 | |
| EDLDPYYSNKKTFIV | 81 | P35499 | |
| DVTTVDPKYNYSKDA | 111 | P03986 | |
| DEYKPLDLSDSTLSY | 286 | O43541 | |
| DIYDPKDYSVTVSSL | 716 | Q14DG7 | |
| IPDAEIYKITATDFY | 91 | O15056 | |
| IYKITATDFYPLQEE | 96 | O15056 | |
| QVELEYFPKSVSEYS | 666 | B5MCY1 | |
| EEEVYISHIYSPQKF | 966 | B5MCY1 | |
| YDDPYKTDVRTNINS | 1546 | P12259 | |
| TQEFYVDYKPTNTET | 476 | Q86VH5 | |
| FPTISADYSQDEKAL | 191 | Q96MK3 | |
| FLKYTVSYDIPVETV | 586 | P25391 | |
| YFNSVSEKPVTREDF | 1296 | P25391 | |
| DKLYTTSPNVEESYL | 541 | Q9UPR0 | |
| RQQAEKDSASTEPYY | 1066 | Q99707 | |
| EDLDPFYSTQKTFIV | 81 | Q14524 | |
| PSYEAAVKSELNRYS | 306 | A6NL88 | |
| DYKADINTQADPYTT | 106 | Q9UIB8 | |
| DPLNKSSYKYEADTV | 26 | Q9H169 | |
| SSIENAVKYNPVYES | 1151 | Q9BZV3 | |
| TLVANPYSYTDKASD | 706 | O60287 | |
| PYSYTDKASDFVQEA | 711 | O60287 | |
| APSESEKLYSFYDLE | 116 | Q9H7B4 | |
| PDDSTYVDITYDFII | 216 | P17787 | |
| KSLDDSSNETIYYEP | 651 | Q9C0B6 | |
| IPAYTSAYLIEEELK | 56 | Q0P6D6 | |
| KDAIVVDPSSNLYYR | 156 | Q16281 | |
| QLEYYASSPDEKALV | 521 | Q9Y2G3 | |
| SPDRQFVYLESDYSK | 106 | Q12884 | |
| PFNETTDLSFLDKYQ | 141 | A0AVT1 | |
| PELSTISEDGKEYYL | 296 | Q8N2E2 | |
| EASSINLSVYEPFKV | 206 | Q9HCE3 | |
| KISLDPTEASYEDGY | 261 | Q92574 | |
| SNTAPLTDYFLKDEY | 321 | Q13107 | |
| KTLSPEDYAAYKEST | 296 | P0CB48 | |
| PVVDSLKYLTSLNYD | 596 | Q8NI27 | |
| SKEDPQTFYYAVAVV | 106 | P02787 | |
| SSAPEVRIYDLSKYD | 411 | Q9ULR3 | |
| TERSKLEDDPLYTSY | 3566 | Q15413 | |
| RAYLEAESQKPDSSY | 36 | A6NEH6 | |
| AESQKPDSSYDYLEE | 41 | A6NEH6 | |
| FVYSYEKLSINESVP | 66 | A0A577 | |
| SYSKLEIPYQAEVLD | 416 | Q92545 | |
| VDLFVPKFSISATYD | 301 | P05543 | |
| EYALTDLEPATEYTL | 1851 | P24821 | |
| LDSSDIYNELKETYP | 1036 | P29144 | |
| YLQDSDPDSFQDYIK | 451 | P14679 | |
| DPDSFQDYIKSYLEQ | 456 | P14679 | |
| YVLSVEQYPELADSA | 2671 | Q9P273 | |
| KETTLSYYKSQDEAP | 381 | Q86UX7 | |
| LYETSYRLSKNEAPE | 216 | Q9UKN8 | |
| ASEILQTPVTEYDLY | 231 | O60656 | |
| YITLESKDISPEDYI | 131 | Q96AE7 | |
| YDAFIVYDTKDPAVT | 891 | Q9NYK1 | |
| EATKSIEPGSDYYEL | 581 | P11137 | |
| TELLIEYYEKIFSTP | 401 | P85298 | |
| YSDPEDESKITFYIL | 111 | P41587 | |
| EVKESYITLAPLYSE | 651 | O60290 | |
| DYYENPAIKEDVSTL | 186 | Q9BV44 | |
| VYESTAPYFSDLQSK | 16 | Q9P272 | |
| YGSVIDTKTEEPYFA | 1051 | Q5TAH2 | |
| PSLSKTEVDQDLTYY | 856 | Q8NEE8 | |
| TNTLSPEKDIYEIYS | 86 | Q9HCL3 | |
| PISKLVVSESYDTYI | 536 | Q8TF42 | |
| TSKDIEQFSTYDFIP | 676 | Q9Y4F4 | |
| EEQLSISLKPYTYEF | 1036 | P48553 | |
| SLSPQDRAAYKEYIS | 636 | P17480 | |
| ETNLTYEDFPTSKYT | 261 | Q9BVG3 | |
| FSDRVVYTPESLYKE | 381 | Q08AF3 | |
| SDSRVDITDLYKYPE | 431 | O95932 | |
| EEELSGTKVSAPYYS | 126 | Q8N5A5 | |
| VYPTSLTKNDLEDFF | 76 | O75795 | |
| SIELSPISKYDEYGF | 551 | Q9BYX2 | |
| RESPTADSVYKYNIF | 146 | Q2M3W8 | |
| YETLVSLDYAISKPD | 176 | Q6ZMS7 | |
| TVSLKTEGPYDSLDY | 1281 | Q9NR99 | |
| KDALVFLNTSYADPE | 331 | O15146 | |
| DVSDSKQFTYYPLVE | 316 | Q00653 | |
| SDPYVKLSLYVADEN | 41 | Q96PU5 |